Skip to main content
Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
3.760
-0.070 (-1.83%)
At close: Nov 20, 2024, 4:00 PM
3.770
+0.010 (0.27%)
Pre-market: Nov 21, 2024, 7:33 AM EST

Canopy Growth Revenue

Canopy Growth had revenue of 62.99M CAD in the quarter ending September 30, 2024, a decrease of -9.49%. This brings the company's revenue in the last twelve months to 280.50M, down -6.17% year-over-year. In the fiscal year ending March 31, 2024, Canopy Growth had annual revenue of 297.15M, down -10.83%.

Revenue (ttm)
280.50M CAD
Revenue Growth
-6.17%
P/S Ratio
n/a
Revenue / Employee
272,591 CAD
Employees
1,029
Market Cap
396.47M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024297.15M-36.11M-10.83%
Mar 31, 2023333.25M-142.45M-29.94%
Mar 31, 2022475.70M-70.95M-12.98%
Mar 31, 2021546.65M147.88M37.08%
Mar 31, 2020398.77M172.43M76.18%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DocGo 694.97M
Revance Therapeutics 256.95M
Akebia Therapeutics 169.88M
Rigel Pharmaceuticals 157.37M
Quanterix 129.33M
Verve Therapeutics 24.40M
4D Molecular Therapeutics 17.00K
Revenue Rankings

CGC News

More News